Published in Epidemiology on November 01, 2009
Rice consumption and urinary arsenic concentrations in U.S. children. Environ Health Perspect (2012) 2.44
Evaluation of the association between arsenic and diabetes: a National Toxicology Program workshop review. Environ Health Perspect (2012) 2.05
Influence of arsenate and arsenite on signal transduction pathways: an update. Arch Toxicol (2010) 1.76
Seafood intake and urine concentrations of total arsenic, dimethylarsinate and arsenobetaine in the US population. Environ Res (2010) 1.75
No association between arsenic exposure from drinking water and diabetes mellitus: a cross-sectional study in Bangladesh. Environ Health Perspect (2010) 1.48
Mortality in young adults following in utero and childhood exposure to arsenic in drinking water. Environ Health Perspect (2012) 1.44
Rejoinder: Arsenic exposure and prevalence of type 2 diabetes: updated findings from the National Health Nutrition and Examination Survey, 2003-2006. Epidemiology (2009) 1.38
Arsenic exposure, diabetes prevalence, and diabetes control in the Strong Heart Study. Am J Epidemiol (2012) 1.25
Creatinine, diet, micronutrients, and arsenic methylation in West Bengal, India. Environ Health Perspect (2011) 1.18
Association of low to moderate levels of arsenic exposure with risk of type 2 diabetes in Bangladesh. Am J Epidemiol (2013) 1.09
Arsenic exposure and incidence of type 2 diabetes in Southwestern American Indians. Am J Epidemiol (2013) 1.05
On confounded fishy results regarding arsenic and diabetes. Epidemiology (2009) 0.93
Long-term exposure to low-level arsenic in drinking water and diabetes incidence: a prospective study of the diet, cancer and health cohort. Environ Health Perspect (2014) 0.91
Arsenic exposure from drinking water and QT-interval prolongation: results from the Health Effects of Arsenic Longitudinal Study. Environ Health Perspect (2013) 0.89
Dietary sources of methylated arsenic species in urine of the United States population, NHANES 2003-2010. PLoS One (2014) 0.89
Arsenic and diabetes. Environ Health Perspect (2013) 0.87
Adjusting for Urinary Creatinine Overestimates Arsenic Concentrations in Diabetics. Cardiorenal Med (2011) 0.86
Urine arsenic concentration and obstructive pulmonary disease in the U.S. population. J Toxicol Environ Health A (2011) 0.83
A dose-response study of arsenic exposure and markers of oxidative damage in Bangladesh. J Occup Environ Med (2014) 0.82
Differences in urinary arsenic metabolites between diabetic and non-diabetic subjects in Bangladesh. Int J Environ Res Public Health (2013) 0.82
Association between Arsenic Exposure and Diabetes: A Meta-Analysis. Biomed Res Int (2015) 0.80
Association of urinary metal profiles with altered glucose levels and diabetes risk: a population-based study in China. PLoS One (2015) 0.79
Urinary arsenic and insulin resistance in US adolescents. Int J Hyg Environ Health (2015) 0.77
Arsenic exposure and type 2 diabetes: results from the 2007-2009 Canadian Health Measures Survey. Health Promot Chronic Dis Prev Can (2015) 0.76
Arsenic exposure is associated with diminished insulin sensitivity in non-diabetic Amish adults. Diabetes Metab Res Rev (2016) 0.75
Association of arsenobetaine with beta-cell function assessed by homeostasis model assessment (HOMA) in nondiabetic Koreans: data from the fourth Korea National Health and Nutrition Examination Survey (KNHANES) 2008-2009. Ann Occup Environ Med (2017) 0.75
Early social attention impairments in autism: social orienting, joint attention, and attention to distress. Dev Psychol (2004) 4.45
Increased mortality from lung cancer and bronchiectasis in young adults after exposure to arsenic in utero and in early childhood. Environ Health Perspect (2006) 4.04
Fifty-year study of lung and bladder cancer mortality in Chile related to arsenic in drinking water. J Natl Cancer Inst (2007) 3.15
Elevated lung cancer in younger adults and low concentrations of arsenic in water. Am J Epidemiol (2014) 2.41
Virion proteins of Kaposi's sarcoma-associated herpesvirus. J Virol (2005) 2.38
Arsenic in drinking water and skin lesions: dose-response data from West Bengal, India. Epidemiology (2003) 2.36
Acute myocardial infarction mortality in comparison with lung and bladder cancer mortality in arsenic-exposed region II of Chile from 1950 to 2000. Am J Epidemiol (2007) 2.36
A Kaposi's sarcoma-associated herpesviral protein inhibits virus-mediated induction of type I interferon by blocking IRF-7 phosphorylation and nuclear accumulation. Proc Natl Acad Sci U S A (2002) 2.30
Children's intellectual function in relation to arsenic exposure. Epidemiology (2007) 2.25
An emerging role for epigenetic dysregulation in arsenic toxicity and carcinogenesis. Environ Health Perspect (2010) 2.16
Arsenic exposure during pregnancy and size at birth: a prospective cohort study in Bangladesh. Am J Epidemiol (2008) 2.06
Case-control study of bladder cancer and drinking water arsenic in the western United States. Am J Epidemiol (2003) 1.88
Bronchiectasis in persons with skin lesions resulting from arsenic in drinking water. Epidemiology (2005) 1.72
Probability estimates for the unique childhood leukemia cluster in Fallon, Nevada, and risks near other U.S. Military aviation facilities. Environ Health Perspect (2004) 1.70
Chromatin remodeling of the Kaposi's sarcoma-associated herpesvirus ORF50 promoter correlates with reactivation from latency. J Virol (2003) 1.70
Case-control study of bladder cancer and exposure to arsenic in Argentina. Am J Epidemiol (2004) 1.67
Kaposi's sarcoma-associated herpesvirus lytic origin (ori-Lyt)-dependent DNA replication: identification of the ori-Lyt and association of K8 bZip protein with the origin. J Virol (2003) 1.63
Arsenic exposure and risk of spontaneous abortion, stillbirth, and infant mortality. Epidemiology (2010) 1.61
Perchlorate in drinking water during pregnancy and neonatal thyroid hormone levels in California. J Occup Environ Med (2010) 1.59
Arsenic methylation and bladder cancer risk in case-control studies in Argentina and the United States. J Occup Environ Med (2006) 1.58
Virion-wide protein interactions of Kaposi's sarcoma-associated herpesvirus. J Virol (2008) 1.54
Decreased urinary beta-defensin-1 expression as a biomarker of response to arsenic. Toxicol Sci (2008) 1.54
Kidney cancer mortality: fifty-year latency patterns related to arsenic exposure. Epidemiology (2010) 1.52
Decrements in lung function related to arsenic in drinking water in West Bengal, India. Am J Epidemiol (2005) 1.52
Lung function in adults following in utero and childhood exposure to arsenic in drinking water: preliminary findings. Int Arch Occup Environ Health (2010) 1.52
Kaposi's sarcoma-associated herpesvirus ori-Lyt-dependent DNA replication: cis-acting requirements for replication and ori-Lyt-associated RNA transcription. J Virol (2004) 1.48
Family correlations of arsenic methylation patterns in children and parents exposed to high concentrations of arsenic in drinking water. Environ Health Perspect (2002) 1.48
Dietary intake and arsenic methylation in a U.S. population. Environ Health Perspect (2005) 1.47
Increased childhood liver cancer mortality and arsenic in drinking water in northern Chile. Cancer Epidemiol Biomarkers Prev (2008) 1.44
Mortality in young adults following in utero and childhood exposure to arsenic in drinking water. Environ Health Perspect (2012) 1.44
The ORF45 protein of Kaposi's sarcoma-associated herpesvirus is associated with purified virions. J Virol (2003) 1.41
Data sharing: not as simple as it seems. Environ Health (2011) 1.40
Nutritional factors and susceptibility to arsenic-caused skin lesions in West Bengal, India. Environ Health Perspect (2004) 1.38
Drinking water arsenic in northern chile: high cancer risks 40 years after exposure cessation. Cancer Epidemiol Biomarkers Prev (2013) 1.35
The temporal stability of arsenic concentrations in well water in western Nevada. Environ Res (2004) 1.34
Selenium and lung cancer: a quantitative analysis of heterogeneity in the current epidemiological literature. Cancer Epidemiol Biomarkers Prev (2004) 1.33
Individual differences in arsenic metabolism and lung cancer in a case-control study in Cordoba, Argentina. Toxicol Appl Pharmacol (2010) 1.30
Functional characterization of Kaposi's sarcoma-associated herpesvirus ORF45 by bacterial artificial chromosome-based mutagenesis. J Virol (2006) 1.29
Kaposi's sarcoma-associated herpesvirus ori-Lyt-dependent DNA replication: involvement of host cellular factors. J Virol (2008) 1.28
Effect of quantitative nuclear image features on recurrence of Ductal Carcinoma In Situ (DCIS) of the breast. Cancer Inform (2008) 1.28
MicroRNA-7 inhibits epithelial-to-mesenchymal transition and metastasis of breast cancer cells via targeting FAK expression. PLoS One (2012) 1.27
Kaposi's sarcoma-associated herpesvirus ori-Lyt-dependent DNA replication: dual role of replication and transcription activator. J Virol (2006) 1.26
P53 alterations in bladder tumors from arsenic and tobacco exposed patients. Carcinogenesis (2003) 1.26
Benzene exposure and risk of non-Hodgkin lymphoma. Cancer Epidemiol Biomarkers Prev (2007) 1.19
Creatinine, diet, micronutrients, and arsenic methylation in West Bengal, India. Environ Health Perspect (2011) 1.18
Increased lung cancer risks are similar whether arsenic is ingested or inhaled. J Expo Sci Environ Epidemiol (2009) 1.17
Coordination of KSHV latent and lytic gene control by CTCF-cohesin mediated chromosome conformation. PLoS Pathog (2011) 1.16
Kaposi's sarcoma-associated herpesvirus ORF45 interacts with kinesin-2 transporting viral capsid-tegument complexes along microtubules. PLoS Pathog (2009) 1.15
Intraindividual variability in arsenic methylation in a U.S. population. Cancer Epidemiol Biomarkers Prev (2005) 1.10
ORF45 of Kaposi's sarcoma-associated herpesvirus inhibits phosphorylation of interferon regulatory factor 7 by IKKε and TBK1 as an alternative substrate. J Virol (2012) 1.10
Transcription mapping and expression patterns of genes in the major immediate-early region of Kaposi's sarcoma-associated herpesvirus. Virology (2002) 1.09
Antagonism of host antiviral responses by Kaposi's sarcoma-associated herpesvirus tegument protein ORF45. PLoS One (2010) 1.07
Genetic polymorphisms in MTHFR 677 and 1298, GSTM1 and T1, and metabolism of arsenic. J Toxicol Environ Health A (2007) 1.05
Efficacy of isoniazid prophylactic therapy in prevention of tuberculosis in children: a meta-analysis. BMC Infect Dis (2014) 1.04
Chronic respiratory symptoms in children following in utero and early life exposure to arsenic in drinking water in Bangladesh. Int J Epidemiol (2013) 1.03
IARC monographs: 40 years of evaluating carcinogenic hazards to humans. Environ Health Perspect (2015) 1.03
Blood concentrations of methionine, selenium, beta-carotene, and other micronutrients in a case-control study of arsenic-induced skin lesions in West Bengal, India. Environ Res (2005) 1.03
Evidence from Chile that arsenic in drinking water may increase mortality from pulmonary tuberculosis. Am J Epidemiol (2010) 1.03
Investigation of genetic polymorphisms and smoking in a bladder cancer case-control study in Argentina. Cancer Lett (2004) 1.02
Arsenic, tobacco smoke, and occupation: associations of multiple agents with lung and bladder cancer. Epidemiology (2013) 1.02
Childhood cancer incidence and arsenic exposure in drinking water in Nevada. Arch Environ Health (2002) 0.99
Evasion and subversion of interferon-mediated antiviral immunity by Kaposi's sarcoma-associated herpesvirus: an overview. J Virol (2011) 0.98
Case-control study of arsenic in drinking water and kidney cancer in uniquely exposed Northern Chile. Am J Epidemiol (2013) 0.98
Essential role of RBP-Jkappa in activation of the K8 delayed-early promoter of Kaposi's sarcoma-associated herpesvirus by ORF50/RTA. Virology (2006) 0.98
Reverse osmosis filter use and high arsenic levels in private well water. Arch Environ Occup Health (2007) 0.98
Mechanisms of autoinhibition of IRF-7 and a probable model for inactivation of IRF-7 by Kaposi's sarcoma-associated herpesvirus protein ORF45. J Biol Chem (2010) 0.97
Comparative functional genomic analysis identifies distinct and overlapping sets of genes required for resistance to monomethylarsonous acid (MMAIII) and arsenite (AsIII) in yeast. Toxicol Sci (2009) 0.97
Arsenic-related chromosomal alterations in bladder cancer. J Natl Cancer Inst (2002) 0.95
Formaldehyde and leukemia: an updated meta-analysis and evaluation of bias. J Occup Environ Med (2010) 0.95
The interaction between the oxytocin and pain modulation in headache patients. Neuropeptides (2013) 0.95
Evaluation of two new arsenic field test kits capable of detecting arsenic water concentrations close to 10 microg/L. Environ Sci Technol (2006) 0.94
Differential regulation of K8 gene expression in immediate-early and delayed-early stages of Kaposi's sarcoma-associated herpesvirus. Virology (2004) 0.94